Disseminated on behalf of Redwood AI Corp. and may include paid advertising.
Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) has joined a Canadian oncology research consortium as a co-applicant in a competitive Terry Fox Research Institute grant supporting the development of Onco-Innovations’ SynoGraph(TM) artificial intelligence platform. The research project will investigate whether causal AI, combined with preclinical research and real-world clinical, genomic and imaging data, can improve predictions of how investigational therapies may perform in human trials. Redwood AI will contribute proprietary data integration, feature engineering and physicochemical modelling methods, working alongside Onco-Innovations and academic research partners that will supply clinical and genomic datasets. The collaboration expands Redwood AI’s applications in life sciences and highlights the potential of combining AI with chemical modelling to support drug development.
To view the full article, visit https://ibn.fm/aMe02
About Redwood AI Corp.
Redwood AI is a technology company developing advanced artificial intelligence and cybersecurity solutions for defense, public safety and life sciences. The company applies artificial intelligence across quantum cybersecurity, scientific research and advanced chemistry applications. Redwood AI’s technology is designed to help organizations prepare for quantum-enabled cybersecurity threats while enabling faster, more efficient development of new therapies and chemistry-driven applications.
NOTE TO INVESTORS: The latest news and updates relating to RDWCF are available in the company’s newsroom at https://ibn.fm/RDWCF
About AINewsWire
AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.
AINW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit www.AINewsWire.com
Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer
AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com
AINewsWire is powered by IBN
